|
Volumn 371, Issue 22, 2014, Pages 2125-2126
|
OHRP and standard-of-care research
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BECLOMETASONE;
GLUCOCORTICOID;
ASTHMA;
CORTICOSTEROID THERAPY;
DISEASE SEVERITY;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEALTH CARE QUALITY;
INFORMATION DISSEMINATION;
INFORMED CONSENT;
LOW DRUG DOSE;
PATIENT CARE;
PATIENT RIGHT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
UNITED STATES;
CLINICAL TRIAL (TOPIC);
COMPARATIVE EFFECTIVENESS;
GOVERNMENT REGULATION;
HUMAN;
HUMAN EXPERIMENT;
LEGISLATION AND JURISPRUDENCE;
PROFESSIONAL STANDARD;
CLINICAL TRIALS AS TOPIC;
COMPARATIVE EFFECTIVENESS RESEARCH;
ETHICS COMMITTEES, RESEARCH;
GOVERNMENT REGULATION;
HUMAN EXPERIMENTATION;
HUMANS;
INFORMED CONSENT;
STANDARD OF CARE;
UNITED STATES;
|
EID: 84922032826
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMe1413296 Document Type: Editorial |
Times cited : (18)
|
References (0)
|